Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EV/Core EBITDA

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.4926.404.985.735.29

What is the latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM ?

The latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM is 9.49 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20259.49
Mar202426.40
Mar20234.98
Mar20225.73
Mar20215.29

How is EV/Core EBITDA of SAMRAT PHARMACHEM Trending?

Years EV/Core EBITDA % Change
Mar2025 9.49
-64.05
Mar2024 26.4
430.12
Mar2023 4.98
-13.09
Mar2022 5.73
8.32
Mar2021 5.29 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EV/Core EBITDA ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹71.5 Cr -10.5% -16% -42.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,768.0 Cr -2.7% -2.2% -0.8% Stock Analytics
DIVIS LABORATORIES ₹169,385.0 Cr -0.7% -1.1% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,242.0 Cr -0.8% 0.8% 12.2% Stock Analytics
CIPLA ₹121,093.0 Cr -1.2% -1.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,799.0 Cr NA 2.4% 0.2% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-10.5%

-16%

-42.7%

SENSEX

-0.4%

-0.2%

2.9%


You may also like the below Video Courses